From: Therapeutic applications of nucleic acid aptamers in microbial infections
Organism | Type of aptamer | Target | Aptamer therapeutic effect | Ref |
---|---|---|---|---|
HBV | DNA | Core protein | -Prevent the assembly of the nucleocapsid -function by suppressing HBV replication | [82] |
HCV | DNA | Envelope Protein | -Inhibition of virus binding to host cells | [90] |
Influenza A virus | DNA | Hemagglutinin protein | -Blocking the binding of virus to target cell receptors -prevention of the virus invasion into the host cells | [83] |
Ebola Virus | RNA | VP35 | -Disrupt the eVP35− NP interaction | [91] |
HIV-1 | RNA | gag protein | -Inhibit HIV-1 replication | [92] |
HSV-1 | RNA | gD protein | -Blocking the gD functions | [85] |
Vaccinia virus | DNA | Hemagglutinin protein | -Recognize proteins expressed on the surface of VV- infected cells | [93] |
Influenza B Virus | RNA | Hemagglutinin protein | -Inhibited HA-mediated membrane fusion | [94] |
SCV | RNA | nsP10 | -Inhibit double-stranded DNA unwinding activity of the helicase | [89] |
Rabies virus | DNA | Blocking the interaction between rabies virus and permissive host cell receptors | -Reduced viral replication in an in vitro infection model | [84] |